A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list ; volume:22 ; number:1 ; day:4 ; month:7 ; year:2024 ; pages:1-13 ; date:12.2024
Pediatric rheumatology ; 22, Heft 1 (4.7.2024), 1-13, 12.2024
- Urheber
-
Slamang, Waheba
Scott, Christiaan
Foster, Helen E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-024-00997-x
- URN
-
urn:nbn:de:101:1-2409231254541.670664804395
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Slamang, Waheba
- Scott, Christiaan
- Foster, Helen E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
The Essential and Optimal Analgesic and Anti-Inflammatory Medicines for Athletes at the Olympic Games
Revising the WHO Essential Medicines List for paediatric rheumatology
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Rheumatic diseases and the heart
Essential medicines in Tanzania: does the new delivery system improve supply and accountability?
Revising the WHO Essential Medicines List for paediatric rheumatology update
Associations between essential medicines and health outcomes for cardiovascular disease
Essential psychiatric medicines: wrong selection, high consumption and social problems
Access to essential medicines: Rationality and consensus in the conflict over intellectual property rights
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
The Essential and Optimal Analgesic and Anti-Inflammatory Medicines for Athletes at the Olympic Games
Revising the WHO Essential Medicines List for paediatric rheumatology
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Rheumatic diseases and the heart
Essential medicines in Tanzania: does the new delivery system improve supply and accountability?
Revising the WHO Essential Medicines List for paediatric rheumatology update
Associations between essential medicines and health outcomes for cardiovascular disease
Essential psychiatric medicines: wrong selection, high consumption and social problems
Access to essential medicines: Rationality and consensus in the conflict over intellectual property rights
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
The Essential and Optimal Analgesic and Anti-Inflammatory Medicines for Athletes at the Olympic Games
Revising the WHO Essential Medicines List for paediatric rheumatology
Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
Rheumatic diseases and the heart
Essential medicines in Tanzania: does the new delivery system improve supply and accountability?
Revising the WHO Essential Medicines List for paediatric rheumatology update
Associations between essential medicines and health outcomes for cardiovascular disease
Essential psychiatric medicines: wrong selection, high consumption and social problems